BIIB241108C162500
- 0.00
- 0.000.00%
Biogen Newsroom
Market Prices in Trump Victory with Index Records | Wall Street Today
Market Trumps Past Records Wednesday Afternoon | Live Stock
Tuesday Market Closed Up, with Presidency in Sight | Wall Street Today
Argus Cuts Biogen's Price Target to $200 From $250
We Want YOU to Submit Questions for Election Night
Are Investors Undervaluing Biogen (BIIB) Right Now?
Monday Market Moves Sideways, Election and FOMC in Sight | Wall Street Today
J.P. Morgan Maintains Biogen(BIIB.US) With Hold Rating, Cuts Target Price to $210
Biogen Call Volume Above Normal and Directionally Bullish
Monday Market Mixed Before Crazy, Pivotal Week | Live Stock
Express News | JP Morgan Maintains Neutral on Biogen, Lowers Price Target to $210
Biogen Analyst Ratings
Biogen Stock Touches 52-week Low at $173.01 Amid Market Challenges
Biogen (BIIB) Loses -6.4% in 4 Weeks, Here's Why a Trend Reversal May Be Around the Corner
Weekly Buzz: Magnificent Mix of Market Reactions
November Starts with a Climb to end Tough Week | Wall Street Today
Friday Market Climbs on Amazon Earnings, Labor Numbers at Four-Year Low | Live Stock
The Boston Globe Explores How Companies Are Working to Advance Medicine and Highlight Innovation at First Annual Future Of Medicine Event
A Quick Look at Today's Ratings for Biogen(BIIB.US), With a Forecast Between $190 to $302
Biogen Partner Eisai Completes FDA Submissions for Injectable Alzheimer's Therapy